Clinical Trial Update: Treatment Patterns and Clinical Outcomes Among Patients With HR+/HER2- mBC Receiving Palbociclib Combination Therapy in the US Community Oncology Setting.

View source ↗

Summary

A completed clinical trial evaluating treatment patterns and clinical outcomes for HR+/HER2- metastatic breast cancer patients treated with palbociclib in combi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Palbociclib (palbociclib)

Snippet

Sponsor: Pfizer | Conditions: Breast Cancer | Status: COMPLETED | Results posted: 2024-01-11